The influence of mongolian new medicine-ii on cardiac function in patients with acute myocardial infarction ( ami ) and cardiomyopathy-review

Mongolian New Medicine-II is a traditional prescription medicine of Mongolian Medicine. It has an important heart strengthening effect on palpitation and chest pain caused by Qi deficiency. It has been used clinically in the management of coronary heart disease, ischemic cardiomyopathy for many years. It has been shown to have excellent outcomes on adverse ventricular remodeling. The primary mode of action of the drug is decrease in expressions of endoplasmic reticulum chaperone GRP78, GRP94, pro-apoptotic factor CHOP and caspase-3.